Anti-CXCR2 Antibodies and Their Uses
翻译题名抗CXCR2抗体及其用途
申请号KR1020227010854
2022-07-04
公开(公告)号KR1020220092859A
公开日期2022-07-04
摘要

It provides anti-CXCR2 antibodies and antigen-binding fragments thereof. The antibody or fragment thereof specifically binds to the N-terminus of the CXCR2 protein, the extracellular domain. In various examples, the antibody or fragment thereof comprises VH CDR1 of SEQ ID NO : 1, VH CDR2 of SEQ ID NO : 2, SEQ ID NO : 3, or VH CDR3 of any one of SEQ ID NO : 7-14, VL CDR1 of SEQ ID NO : 4, VL CDR2 of SEQ ID NO : 5, and VL CDR3 of SEQ ID NO : 6, or their respective variants. Methods of using antibodies or fragments thereof for treating and diagnosing diseases such as cancer and inflammatory diseases are also provided.

翻译摘要

本发明提供了抗CXCR2抗体及其抗原结合片段。 抗体或其片段特异性结合CXCR2蛋白的N-末端,即细胞外结构域。 在各种实施例中, 抗体或其片段包含SEQ ID NO : VH CDR1: 1, SEQ ID NO : 2的VH CDR2,SEQ ID NO : 3,或SEQ ID NO : 7-14,SEQ ID NO : 4的VL CDR1,SEQ ID NO : 5的VL CDR2,和SEQ ID NO : 6的VL CDR3中任一个的VH CDR3,或它们各自的变体。 还提供了使用抗体或其片段治疗和诊断疾病如癌症和炎性疾病的方法。

当前权利人SHANGHAITECH UNIV
专利代理人특허법인코리아나
代理机构특허법인코리아나
专利申请人SHANGHAITECH UNIV